The prolactin response to fenfluramine in depression: Effects of melancholia and baseline cortisol

Journal of Psychopharmacology

Volumn 17, Issue 1, 2003, Pages 97-102

  Mulder, Roger T ^a   Porter, Richard J ^a   Joyce, Peter R ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Cortisol; Depressive disorder; Fenfluramine; Prolactin; Serotonin; Tryptophan

Indexed keywords

FENFLURAMINE; HYDROCORTISONE; PROLACTIN; TRYPTOPHAN;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; FEMALE; HORMONE RESPONSE; HUMAN; MAJOR DEPRESSION; MALE; MELANCHOLIA; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM;

ADOLESCENT; ADULT; AREA UNDER CURVE; BODY MASS INDEX; DEPRESSIVE DISORDER, MAJOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FENFLURAMINE; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; PROLACTIN; SEROTONIN UPTAKE INHIBITORS; SEX FACTORS; TIME FACTORS;

EID: 0037347676     PISSN: 02698811     EISSN: None     Source Type: Journal    
DOI: 10.1177/0269881103017001711     Document Type: Article

References (38)

1. American Psychiatric Association (1980) Diagnostic and statistical manual of mental disorders DSM-III, 3rd edn. American Psychiatric Association, Washington DC
2. Carney M W P, Roth M, Garside R F (1965) The diagnosis of depressive syndromes and the prediction of ECT response. Br J Psychiatry 111: 659-674
3. Coccaro E F, Kavoussi R J, Cooper T B, Hauger R (1996a) 5-HT3 receptor antagonism by ondansetron does not attenuate prolactin response to d-fenfluramine challenge in healthy human subjects. Psychopharmacology 127: 108-112
4. Coccaro E F, Kavoussi R J, Oakes M, Cooper T B, Hauger R (1996b) 5-HT2a/2c receptor blockade by amesergide fully attenuates prolactin response to d-fenfluramine challenge in physically healthy human subjects. Psychopharmacology 126: 24-30
5. Coccaro E F, Kavoussi R J, Cooper T B, Hauger R (1998) Acute tryptophan depletion attenuates the prolactin response to d- fenfluramine challenge in healthy human subjects. Psychopharmacology 138: 9-15
6. Correa H, Duval F, Mokrani M, Bailey P, Tremeau F, Staner L, Diep T S, Hode Y, Crocq M A, Macher J P (2000) Prolactin response to D-fenfluramine and suicidal behavior in depressed patients. Psychiatry Res 93: 189-199
7. Cowen P J (2002) Cortisol, serotonin and depression: all stressed out? BrJ Psychiatry 180: 99-100
8. Deakin J F, Pennell I, Upadhyaya A J, Lofthouse R (1990) A neuroendocrine study of 5HT function in depression: evidence for biological mechanisms of endogenous and psychosocial causation. Psychopharmacology 101: 85-92
9. Elder P A, Lewis J G (1985) An enzyme-linked immunosorbent assay (ELISA) for plasma testosterone. J Steroid Biochem 22: 635-638
10. Fava M, Vuolo R D, Wright E C, Nierenberg A A, Alpert J E, Rosenbaum J F (2000) Fenfluramine challenge in unipolar depression with and without anger attacks. Psychiatry Res 94: 9-18
11. Goodall E M, Cowen P J, Franklin M, Silverstone T (1993) Ritanserin attenuates anorectic, endocrine and thermic responses to d-fenfluramine in human volunteers. Psychopharmacology 112: 461-466
12. Hamilton M (1960) A rating scale for depression. J Neurol Neurosug Psychiatry 23: 56-62
13. Joyce P R (1994) Predictors for treatment response and treatment selection. Curr Opin Psychiatry 7: 26-29
14. Lerer B, Gillon D, Lichtenberg P, Gorfine M, Gelfin Y, Shapira B (1996) Interrelationship of age, depression, and central serotonergic function: evidence from fenfluramine challenge studies. Int Psychogeriatr 8: 83-102
15. Lichtenberg P, Shapira B, Gillon D, Kindler S, Cooper T B, Newman M E, Lerer B (1992) Hormone responses to fenfluramine and placebo challenge in endogenous depression. Psychiatry Res 43: 137-146
16. Lopez-Ibor Jr J J, Saiz-Ruiz J, Iglesias L M (1989) Neuroendocrine challenges in the diagnosis of depressive disorders. Br J Psychiatry 154: 73-76
17. Maes M, D'Hondt P, Suy E, Minner B, Vandervorst C, Raus J (1991) HPA-axis hormones and prolactin responses to dextrofenfluramine in depressed patients and healthy controls. Progr Neuropsychopharmacol Biol Psychiatry 15: 781-790
18. Mann J J, McBride P A, Malone K M, DeMeo M, Keilp J (1995) Blunted serotonergic responsivity in depressed inpatients. Neuropsychopharmacology 13: 53-64
19. McBride P A, Tierney H, DeMeo M, Chen J S, Mann J J (1990) Effects of age and gender on CNS serotonergic responsivity in normal adults. Biol Psychiatry 27: 1143-55
20. Mitchell P, Smythe G (1990) Hormonal responses to fenfluramine in depressed and control subjects. J Affect Disord 19: 43-51
21. Mitchell P, Smythe G, Parker G, Wilhelm K, Hickie I, Brodaty H, Boyce P (1990) Hormonal responses to fenfluramine in depressive subtypes. Br J Psychiatry 157: 551-557
22. Muldoon M F, Manuck S B, Jansma C L, Moore A L, Perel J, Mann J J (1996) D, L-fenfluramine challenge test: experience in nonpatient sample. Biol Psychiatry 39: 761-768
23. Newman M, Shapira B, Lerer B (1998) Evaluation of central serotonergic function in affective and related disorders by the fenfluramine challenge test: a critical review. Int J Neuropsychopharmacol 1: 49-69
24. O'Keane V, Dinan T G (1991) Prolactin and cortisol responses to d-fenfluramine in major depression: evidence for diminished responsivity of central serotonergic function. Am J Psychiatry 148: 1009-1015
25. O'Keane V, O'Hanlon M, Webb M, Dinan T (1991) d- Fenfluramine/prolactin response throughout the menstrual cycle: evidence for an eostrogen-induced alteration. Clin Endocrinol 34: 289-292
26. Park S B, Williamson D J, Cowen P J (1996) 5-HT neuroendocrine function in major depression: prolactin and cortisol responses to D-fenfluramine. Psychol Med 26: 1191-1196
27. Porter R J, Gallagher P, Watson S, Smith M S, Young A H (2001) Elevated prolactin responses to L-tryptophan infusion in medication-free depressed patients. J Psychopharmacol 15 (Suppl A): 13
28. Power A C, Cowen P J (1992) Neuroendocrine challenge tests: assessment of 5-HT function in anxiety and depression. Mol Aspects Med 13: 205-220
29. Price L H, Charney D S, Delgado P L, Heninger G R (1991) Serotonin function and depression: neuroendocrine and mood responses to intravenous L-tryptophan in depressed patients and healthy comparison subjects. Am J Psychiatry 148: 1518-1525
30. Spitzer R, Williams J (1988) Revised diagnostic criteria and a new structured interview for diagnosing anxiety disorders. J Psychiatr Res 22 (Suppl 1): 55-85
31. Spitzer R L, Williams J B, Gibbon M, First M B (1992) The structured clinical interview for DSM-III-R (SCID). I: History, rationale, and description. Arch Gen Psychiatry 49: 624-629
32. Strickland P L, Deakin J F, Percival C, Dixon J, Gater R A, Goldberg D P (2002) Biosocial origins of depression in the community. Interactions between social adversity, cortisol and serotonin neurotransmission. Br J Psychiatry 180: 168-173
33. Targum S D (1990) Differential responses to anxiogenic challenge studies in patients with major depressive disorder and panic disorder. Biol Psychiatry 28: 21-34
34. van Praag H M (1990) Two-tier diagnosing in psychiatry. Psychiatry Res 34: 1-11
35. van Praag H M (1992) Reconquest of the subjective. Against the waning of psychiatric diagnosing. Br J Psychiatry 160: 266-271
36. van Praag H M (1993) Make believes in psychiatry or the perils of progress. Brunner Mazel, New York
37. Walsh A E, Oldman A D, Franklin M, Fairburn C G, Cowen P J (1995) Dieting decreases plasma tryptophan and increases the prolactin response to d-fenfluramine in women but not men. J Affect Disord 33: 89-97
38. World Health Organisation (WHO) (1978) Mental disorders: glossary and guide to their classification in accordance with the ninth revision of the International Classification of Disease (ICD-9). WHO, Geneva